PROFFERED PAPERS
Monday, March 3   —  8:00 AM   —  CC 205/207


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




Section D - GYNECOLOGIC PATHOLOGY
Chaired by: Xavier Matias-Giui and Lora Hedrick Ellenson



TimeTitle and AuthorsItinerary
Planner
8:00 Adenocarcinoma of the Lower Uterine Segment: A Unique Subset of Endometrial Carcinoma (1041)
S Westin, R Broaddus - M.D. Anderson Cancer Center, Houston, TX
Add
8:15 Microsatellite Instability Status and Clinicopathologic Profile of Endometrial Cancer in Young Women (d"50 Years) (1036)
G Toledo, WB Growdon, D Dias-Santagata, A Ganguly, M Aubá, AJ Iafrate, E Oliva - Massachusetts General Hospital, Boston, MA; University Hospital, Pamplona, Spain
Add
8:30 IHC for DNA-MMR in EEC in a Selected Group of Patients (937)
K Garg, N Kauff, J Hansen, K Kosarin, J Shia, RA Soslow - MSKCC, New York, NY
Add
8:45 PTEN Is a Biomarker for Endometrial Glandular Neoplasms That Detects Histologically Occult Precursors ("Latent Precancers") Years in Advance of Clinically Diagnosible Disease (979)
NM Monte, MC Lin, LJ Phang, YK Chun, A Ferenczy, C Eng, K Zbuk, GL Mutter - Brigham and Women's Hospital, Boston, MA; National Taiwan University Hospital, Taipei, Taiwan; SMBD-Jewish General Hospital, Montreal, QC, Canada; Cheil General Hospital & Womens Healthcare Center, Kwandong University College of Medicine, Seoul, Korea; Cleveland Clinic Foundation, Cleveland, OH
Add
9:00 Presence of Endometrial Adenocarcinoma-In-Situ in Complex Atypical Endometrial Hyperplasia Is Associated with Increased Risk of Endometrial Adenocarcinoma in Subsequent Hysterectomy (978)
K Mittal, M Sebenik, C Irwin, Z Yan, D Popiolek, J Curtin, J Palazzo - New York University School of Medicine, New York, NY; North Broward Medical Center, Deerfield Beach, FL; Thomas Jefferson University Hospital, Philadelphia, PA
Add
9:15 Routine Histologic Parameters Can Predict the Presence of Endometrial Carcinoma Following an Endometrial Biopsy Showing Complex Atypical Hyperplasia: A Clinicopathologic Study of 204 Cases (1050)
C Zhang, YE Wang, F Liu, CJ Sung, MM Steinhoff, M Lomme, J Barroeta, WD Lawrence - Women & Infants Hospital of Rhode Island, Warren Alpert Medical School of Brown University, Providence, RI
Add
9:30 RECESS, EXHIBITS, POSTER SESSION I  
11:00 Genetic Alterations of Uterine Fibroids in Hereditary Leiomyomatosis and Renal Cancer Syndrome (1021)
J Sanz, L Teller, C Vockes, WM Linehan, J Sanz-Esponera, MJ Merino - Hospital Clinico San Carlos, Madrid, Spain; NCI, Bethesda, MD
Add
11:15 Clinicopathologic Characterization of Myxoid Mesenchymal Neoplasms of the Uterus (890)
V Anandan, C Moosavi, M Miettinen - Armed Forces Institute of Pathology, Washington, DC
Add
11:30 Molecular and Immunohistochemical Evidence for Origin of Uterine Leimyosarcomas from Associated Leiomyoma and Symplastic Leiomyoma like Areas (916)
F Chen, GA Toruner, JJ Wei, K Rijhvani, R Kurvathi, D Streck, J Dermody, K Mittal - New York University School of Medicine, New York, NY; UMDNJ-NJ Medical School, Institute of Genomic Medicine, Newark, NJ
Add
11:45 Intravenous Leiomyomatosis: An Unusual Intermediate between Benign and Malignant Uterine Smooth Muscle Tumors (985)
MR Nucci, P Dal Cin, J Hodge, M Hollowell, CN Otis, JL Hornick, CC Morton, BJ Quade - Brigham and Women's Hospital/Harvard Medical School, Boston, MA; Baystate Medical Center, Springfield, MA
Add